Bottom line
What is BIVRX's expense ratio?
BIVRX's expense ratio is 3.3%, or about $330 a year on every $10,000 invested. That is more expensive than 99% of large blend funds we track (median 0.83%). It has no front-end sales load. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Mar 2, 2026
BIVRX fee table
| Net expense ratio | 3.3% |
|---|---|
| Gross expense ratio | 3.32% |
| Management fee | 1.74% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 1.32% |
| Acquired fund fees | 0.01% |
| Fee waiver / reimbursement | -0.02% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
| Redemption fee | -1% |
Source: Fund prospectus fee table, filed Mar 2, 2026
What BIVRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| BIVRX | $333 | $1,019 | $1,729 | $3,611 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 3.3% expense ratio costs roughly $150,300 in lost growth, versus about $46,700 for the median large blend fund (0.83%).